Overview
Mohammad Shahla practices practicing medicine in Charleroi, Belgium.
His clinical expertise encompasses Throat Cancer, Laryngeal Cancer, Thyroidectomy, and Laryngectomy.
He is actively involved in clinical research, co-authoring 14 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Mohammad Shahla
Is Mohammad Shahla a top-rated expert for Throat Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Mohammad Shahla is classified as an Experienced expert for Throat Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Mohammad Shahla participate in research or clinical trials?
Yes. Mohammad Shahla has published 14 articles and abstracts on conditions like Throat Cancer. You can view a list of Mohammad Shahla's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Laryngeal CancerMr. Shahla isExperienced. Learn about Laryngeal Cancer.
- LaryngectomyMr. Shahla isExperienced. Learn about Laryngectomy.
- Throat CancerMr. Shahla isExperienced. Learn about Throat Cancer.
- ThyroidectomyMr. Shahla isExperienced. Learn about Thyroidectomy.